Overlap syndrome in late-onset systemic lupus erythematosus with lupus nephritis and MPO-ANCA pauci-immune glomerulonephritis and tuberculosis: an uncommon association
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | |
| dc.contributor.author | Dulce Muñoz, Jaime Arturo | |
| dc.contributor.author | Aroca-Martinez, Gustavo | |
| dc.contributor.author | Seni, Christian | |
| dc.contributor.author | Perea Rojas, Diana Marcela | |
| dc.contributor.author | CABARCAS BARBOSA, OMAR | |
| dc.contributor.author | Niño Hernández, Lucia Mercedes | |
| dc.contributor.author | Gaivao Arciniegas, Dario Jose | |
| dc.contributor.author | García Jarava, Camila Maria | |
| dc.contributor.author | Olivares Olmos, Marianela | |
| dc.contributor.author | Seni Hernandez, Sebastian Andre | |
| dc.contributor.author | Pérez Jiménez, Valentina | |
| dc.contributor.author | Rojas-Torres, Indiana-Luz | |
| dc.date.accessioned | 2025-03-05T14:42:02Z | |
| dc.date.available | 2025-03-05T14:42:02Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Systemic lupus erythematosus is a systemic autoimmune pathology that generally presents in young people and manifests acutely, while its late presentation in people over 50 years of age is rare and insidious. Vasculitis is a pathology that afects any vessel producing fbrinoid necrosis, and presents with a positive antineutrophil cytoplasmic antibody. Te concomitance of these two entities is rare and leads to worse clinical outcomes. We present a 73-year-old female patient who presented with rapidly progressive glomerulonephritis requiring renal replacement therapy, pulmonary tuberculosis, late-onset lupus erythematosus with lupus nephritis, and a positive result for neutrophil cytoplasmic antibody. An immune-mediated extracapillary proliferative glomerulonephritis was found when the biopsy was performed, with obvious signs of vasculitis, an overlap syndrome was found between these entities. She was initially treated with antituberculosis therapy, boluses of methylprednisolone and continued with intermittent renal replacement therapy; however, due to the severity of his pathologies, she had a fatal outcome. Te concomitance between these autoimmune pathologies is unusual; there is a late-onset overlap syndrome between lupus nephritis accompanied by myeloperoxidase-antineutrophil cytoplasmic antibody and pauci-immune glomerulonephritis. Te dual presentation es tablishes clinical challeng. | spa |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.1155/crin/5285961 | |
| dc.identifier.issn | 20906641 (Impreso) | |
| dc.identifier.issn | 2090665X (Electrónico) | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/16340 | |
| dc.identifier.url | https://onlinelibrary.wiley.com/doi/full/10.1155/crin/5285961 | |
| dc.language.iso | eng | |
| dc.publisher | Wiley | spa |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
| dc.source | Case Reports in Nephrology | eng |
| dc.subject | ANCA | spa |
| dc.subject.keywords | ANCA | eng |
| dc.subject.keywords | ANCA-associated vasculitis | eng |
| dc.subject.keywords | Antibodies | eng |
| dc.subject.keywords | Antineutrophil cytoplasmic | eng |
| dc.subject.keywords | Glomerulonephritis | eng |
| dc.subject.keywords | Erythematosus | eng |
| dc.subject.keywords | Lupus nephritis | eng |
| dc.subject.keywords | MPO | eng |
| dc.subject.keywords | Myeloperoxidase | eng |
| dc.subject.keywords | Systemic | eng |
| dc.subject.keywords | Vasculitis | eng |
| dc.title | Overlap syndrome in late-onset systemic lupus erythematosus with lupus nephritis and MPO-ANCA pauci-immune glomerulonephritis and tuberculosis: an uncommon association | spa |
| dc.type.driver | info:eu-repo/semantics/article | |
| dc.type.spa | Artículo científico | |
| dcterms.references | G. J. Pons-Estel, G. S. Alarcón, L. Scofeld, L. Reinlib, and G. S. Cooper, “Understanding the Epidemiology and Pro gression of Systemic Lupus Erythematosus,” Seminars in Arthritis and Rheumatism 39, no. 4 (2010): 257–268. | eng |
| dcterms.references | M. Torres-Bustamante, D. Palomino-Suárez, A. M. Celis, S. F. Nuñez, and A. P. Hernández-Sierra, “Caracterización Clínica de Pacientes con nefropatía lúpica en Santander, la Importancia de la biopsia Renal,” Revista Colombiana de Nefrolog´ıa 6, no. 2 (2019). | spa |
| dcterms.references | D. G. Fernández-Ávila, S. Bernal-Macías, D. N. Rincón-Riaño, J. M. Gutiérrez Dávila, and D. Rosselli, “Prevalence of Systemic Lupus Erythematosus in Colombia: Data From the National Health Registry 2012–2016,” Lupus 28, no. 10 (2019). | eng |
| dcterms.references | A. Richard and M. S. McPherson, Henrys Clinical Diagnosis and Management by Laboratory Methods 23e (2017). | eng |
| dcterms.references | J. Narvaez, “Systemic Lupus Erythematosus 2020,” ´ Medicina Clínica 155, no. 11 (2020): 494–501. | eng |
| dcterms.references | C. D. Ochoa, F. Ramírez, G. Quintana, et al., “Epidemiología de las Vasculitis Primarias en Colombia y su Relación con lo Informado para Latinoamérica,” ´ Revista Colombiana de Reumatología 16, no. 3 (2009). | spa |
| dcterms.references | M. Aringer, K. Costenbader, D. Daikh, et al., “European League Against Rheumatism/American College of Rheumatology Classifcation Criteria for Systemic Lupus Erythematosus,” Arthritis & Rheumatology 71, no. 9 (2019). | eng |
| dcterms.references | H. D. Aguirre, A. F. Posada López, J. E. Aponte Monsalve, and M. F. Estupiñán, “Lupus Eritematoso Sistémico en el Anciano: Una Presentación Atípica de una Enfermedad Común,” Revista Colombiana de Reumatología 21, no. 2 (2014). | spa |
| dcterms.references | P. K. Bundhun, A. Kumari, and F. Huang, “Diferences in Clinical Features Observed Between Childhood-Onset versus Adult-Onset Systemic Lupus Erythematosus,” Medicine (United States) 96, no. 37 (2017). | eng |
| dcterms.references | G. S. Markowitz and V. D. D’Agati, “Te ISN/RPS 2003 Classifcation of Lupus Nephritis: An Assessment at 3 Years,” Kidney International 71 (2007). | eng |
| dcterms.references | K. Yaseen and B. F. Mandell, “ANCA Associated Vasculitis (AAV): A Review for Internists,” Postgraduate Medicine 135 (2023). | eng |
| dcterms.references | M. C. Martínez Ávila, A. J. Almanza Hurtado, J. D. Rodríguez Blanco, T. Rodríguez Yanes, R. Daza Arnedo, and G. Aroca Martínez, “Nefropatía Lúpica: Una Puesta Al Día,” Revista Colombiana de Reumatología 30, no. 3 (2023). | spa |
| dcterms.references | D. Xibille-Friedmann, M. Pérez-Rodríguez, S. Carrillo-Vázquez, et al., “Guía de Práctica Clínica Para el Manejo del Lupus Eritematoso Sistémico Propuesta por el Colegio Mexicano de Reumatología,” Reumatología Clínica 15, no. 1 (2019). | spa |
| dcterms.references | E. R. Rubio, V. Emperiale, P. P. Ruiz, and N. G. Castañeda, “Systemic Lupus Erythematosus (I),” Medicine (Spain). 13, no. 31 (2021): 1739–1750. | eng |
| dcterms.references | J. H. Choi, D. J. Park, J. H. Kang, et al., “Comparison of Clinical and Serological Diferences Among Juvenile-, Adult-, and Late-Onset Systemic Lupus Erythematosus in Korean Patients,” Lupus 24, no. 12 (2015): 1342–1349. | eng |
| dcterms.references | M. Gajic-Veljic, B. Lekic, M. Nikolic, J. Lalosevic, B. Stojimirovic, and B. Bonaci-Nikolic, “Level and Avidity of Antineutrophil Cytoplasmic Antibodies Specifc to Lacto ferrin Are Useful Biomarkers in Systemic Lupus Eryth ematosus,” Clinical Rheumatology 41, no. 3 (2022): 709–720, https://doi.org/10.1007/s10067-021-05926-x. | eng |
| dcterms.references | H. F. Pan, X. H. Fang, G. C. Wu, et al., “Anti-Neutrophil Cytoplasmic Antibodies in New-Onset Systemic Lupus Erythematosus and Lupus Nephritis,” Infammation 31, no. 4 (2008): 260–265, https://doi.org/10.1007/s10753-008-9073-3. | eng |
| dcterms.references | Y. Pan and L. He, “Perinuclear Anti-Neutrophil Cytoplasmic Antibody in Systemic Lupus Erythematosus Indicates More Severe Condition,” Clinical Biochemistry 89 (2021): 38–43, https://doi.org/10.1016/j.clinbiochem.2020.12.004 | eng |
| dcterms.references | T. Turner-Stokes, H. R. Wilson, M. Morreale, et al., “Positive Antineutrophil Cytoplasmic Antibody Serology in Patients with Lupus Nephritis is Associated With Distinct Histopath ologic Features on Renal Biopsy,” Kidney International 92, no. 5 (2017): 1223–1231, https://doi.org/10.1016/j.kint.2017.04.029. | eng |
| dcterms.references | J. Rojas and M. Praga, “Nefropatía Lúpica. Lupus Eritematoso Sistémico,” Nefrología al día. 1, no. 4 (2023): 8–15 | spa |
| dcterms.references | M. Celinska-Lówenhof and J. Musiał, “Late-Onset Systemic ¨ Lupus Erythematosus: Clinical Manifestations, Course, and Prognosis,” Polskie Archiwum Medycyny Wewnetrznej 125, no. 7–8 (2015): 497–499. | spa |
| dcterms.references | F. Yu, Y. Tan, G. Liu, S. X. Wang, W. Z. Zou, and M. H. Zhao, “Clinicopathological Characteristics and Outcomes of Pa tients with Crescentic Lupus Nephritis,” Kidney International 76, no. 3 (2009): 307–317. | spa |
| oaire.version | info:eu-repo/semantics/publishedVersion |